ATLAS ARTERIA (ALX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALX

ALX - ATLAS ARTERIA

FNArena Sector : Infrastructure & Utilities
Year End: December
GICS Industry Group : Transportation
Debt/EBITDA: 29.2
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Atlas Arteria, formerly known as Macquarie Atlas Roads, is a global owner, operator and developer of toll roads. It was created and listed in 2010 following the restructuring of the Macquarie Infrastructure Group.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.96

07 Mar
2025

-0.060

OPEN

$5.02

-1.20%

HIGH

$5.05

1,767,184

LOW

$4.96

TARGET
$5.287 6.6% upside
OTHER COMPANIES IN THE SAME SECTOR
AGL . AIA . APA . CEN . DBI . DBI . GNE . GNP . MEZ . ORG . SRJ . TCL .
FNARENA'S MARKET CONSENSUS FORECASTS
ALX: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx 19.0 34.9 xxx
DPS (cps) xxx 0.0 40.0 xxx
EPS Growth xxx 7.4% 84.1% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 14.2 xxx
Dividend Yield xxx N/A 8.1% xxx
Div Pay Ratio(%) xxx N/A 114.5% xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 24/09 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx19.0
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx145.9 M
Book Value Per Share xxxxxxxxxxxxxxx435.1
Net Operating Cash Flow xxxxxxxxxxxxxxx717.9 M
Net Profit Margin xxxxxxxxxxxxxxx188.69 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx4.39 %
Return on Invested Capital xxxxxxxxxxxxxxx3.46 %
Return on Assets xxxxxxxxxxxxxxx3.37 %
Return on Equity xxxxxxxxxxxxxxx4.39 %
Return on Total Capital xxxxxxxxxxxxxxx-0.09 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx136.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx113 M
Long Term Debt xxxxxxxxxxxxxxx1,736 M
Total Debt xxxxxxxxxxxxxxx1,848 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx352 M
Price To Book Value xxxxxxxxxxxxxxx1.09

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx1.1 M
Capex % of Sales xxxxxxxxxxxxxxx0.75 %
Cost of Goods Sold xxxxxxxxxxxxxxx124 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx30 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx5,632 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

28/02/2025

3

Equal-weight

$5.26

6.05%

Atlas Arteria delivered 2025 distribution guidance of $0.40 per security, marginally ahead of Morgan Stanley's forecast.

The broker notes the company is refining its future distribution target to at least $0.40, adding a 90-110% free cash flow to its guided payout.

Chicago Skyway EBITDA in 2024 was up 4%, less than Morgan Stanley expected, owing to higher operating expenses.

Dulles Greenway EBITDA of US$61m was up 7% and in line with expectations. Equal-weight. Target is $5.26. Industry View: In-Line.

FORECAST
Morgan Stanley forecasts a full year FY25 dividend of 40.00 cents and EPS of 34.00 cents.
Morgan Stanley forecasts a full year FY26 dividend of 38.00 cents and EPS of 31.00 cents.

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

03/02/2025

-1

No Rating

-

Jarden notes Atlas Arteria's 4Q24 update showed traffic and revenue continue to improve with a weighted average of 2.9% and 6.9% for traffic and revenue growth respectively.

Based on FY24 distribution guidance of 40c, the company currently trades on an 8.2% distribution yield, equating to 370bps spread over Australian 10-yr bond yield. Listed peer Transurban ((TCL)) with 4.9% distribution yield trades at a narrower 17bps spread but Atlas' yield reflects its higher risk profile, Jarden highlights.

Atlas' traffic result has minimal implication for Transurban, the broker notes. Jarden is under research restriction, so no rating and no target price.

ALX STOCK CHART